DeannaSMitchellMD

PubMed

• 3 citations
  A pilot study of genomic-guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high-risk neuroblastoma.
  Jacqueline M Kraveka, Elizabeth C Lewis, Genevieve Bergendahl, William Ferguson, Javier Oesterheld
  Cancer Reports. 2022-11-01
• 11 citations
  Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion
  Sara A. Byron, William P.D. Hendricks, Abhinav Nagulapally, Jacqueline M. Kraveka, William S. Ferguson
  Cancer Research. 2021-10-05
• 35 citations
  A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastoma
  Elizabeth C. Lewis, Jacqueline M. Kraveka, William S. Ferguson, Don Eslin, Valerie I. Brown
  International Journal of Cancer. 2020-12-01

Journal Articles

• A Phase 1 Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients with Refractory or Recurrent Neuroblastoma or Medulloblastoma  
  Mitchell D, Bergendahl G, Ferguson W, Roberts W, Higgins T, Ashikaga T DeSarno M, Kaplan J, Kraveka J, Eslin D, VanderWerff A, Hanna G, Sholler GS, Pediatric Blood & Cancer, 1/1/2016
• A phase I trial of DFMO targeting polyamine addiction in patients with relapsed/refractory neuroblastoma  
  Sholler GS, Gerner EW, Bergendahl G, MacArthru RB, VanderWerff A, Ashikaga T, Bond JP, Ferguson W, Roberts, W, Wada RK, Eslin D, Kraveka JM, Kaplan J, Mitchell D, Pari..., PLOS ONE, 1/1/2015
• Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma  
  Sholler GS, Bond J, Bergendahl G, Dutta A, Dragon J, Neville K, Ferguson W, Roberts W, Eslin D Kraveka J, Kaplan J,Mitchell D, Parikh N, Merchant M, Ashikaga T, Hanna..., Cancer Medicine, 1/1/2015
• Using a Rhabdomyosarcoma Patient-Derived Xenograft to Examine Precision Medicine Approaches and Model Acquired Resistance  
  David J. Monsma, David M. Cherba, Patrick Richardson, Sean Vance, Sanjeet Rangarajan, Dawna Dylewski, Emily Eugster, Stephanie B. Scott, Nicole Beuschel, Paula J. Davi..., Pediatric Blood Cancer, 1/1/2014
• Targeting receptor-activator of nuclear kappaB ligand in aneurysmal bone cysts: verification of target and therapeutic response  
  Pelle DW, Ringler JW, Peacock JD, Kampfschulte K, Scholten DJ, Davis MM, Mitchell DS, Steensma MR, Transl Res, 1/1/2014
• Association  of low von willibrand activity (VWA) with increased intra-operative bleeding in pediatric posterior spinal fusion  
  Hassan N, Cassidy J, Halanski M, Braunreiter C, Mitchell D, Shoemaker A, Rajasekaran S, Crit Care Med, 1/1/2013
• Association of Low Von wilibrandt activity (VWA) with increased intra-operative bleeding in pediatric Posterior Spinal Fusion  
  Nabil Hassan, Jeffery Cassidy, Mathew Halanski , Chi Braunreiter, Deanna Mitchell, Allen shoemaker Surender Rajasekaran, Crit Care Med, 1/1/2013
• Transfusion as an independent predictor of severity in critically ill children  
  Hilary Beauchamp, Nabil Hassan, Akunne Ndika, Sandra Zuiderveen, Anthony Olivero, Alan Davis, Richard Hackbarth1, Surender Rajasekaran, Crit Care Med, 1/1/2013
• A pilot trial testing the feasibility of using molecular-guided therapy in patients with recurrent neuroblastoma  
  Saulnier Sholler, Giselle L., William Ferguson, Genevieve Bergendahl, Erika Currier, Shannon R. Lenox, Jeffrey Bond, Marni Slavik, William Roberts, Deanna Mitchell, Do..., Journal of Cancer Therapy, 1/1/2012
• Blood management in pediatric spinal deformity surgery: review of a 2-year experience  
  Hassan N, Kurt B, Mitchell D, Transfusion, 1/1/2011
• Focal nodular hyperplasia in oncology patients  
  Junewick J, Mitchell D, Pediatr Radiol, 1/1/2006
• Primary Thoracoscopic Gross Total Resection of Neuroblastoma  
  DeCou JM, Schlatter, MG, Mitchell, D, Abrams, RS, J Laparoendoscopic & Advanced Surgical Techniques, 1/5/2005
• Medical management of fibrodysplasia ossificans progressiva: current treatment considerations  
  Kaplan FS, Glaser DL, Shore EM, Emerson S, Mitchell D and The FOP Clinical Consortium, Clin Proc Third Intl Symp FOP, 1/1/2001
• Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation  
  Sklar CA, Mertens AC, Walter A, Mitchell D, Nesbit ME, O’Leary M, Hutchinson R, Meadows AT and Robison LL, Med Pediatr Onc, 1/1/2000
• PET hydroxyephedrine imaging of neuroblastoma  
  Shulkin BL, Wieland DM, Baro ME, Ungar DR, Mitchell DS, Dole MG, Rawwas JB, Castle VP, Sisson JC, Hutchinson RJ, J Nuclear Med, 1/1/1996
• Hutchinson RJ: PET hydroxyephedrine imaging of neuroblastoma  
  Shulkin BL, Wieland DM, Baro ME, Ungar DR, Mitchell DS, Dole MG, Rawwas JB, Castle VP, Sisson JC, J Nuclear Med, 1/1/1996
• Neoplasms in a pediatric population: 2-[f-18]-Fluoro-2-deoxy-D-glucose PET studies  
  Shulkin BL, Mitchell DS, Ungar DR, Prakash D, Dole MG, Castle VP, Hernandez RJ, Koeppe RA, Hutchinson RJ, Radiology, 1/1/1995
• SAS, a gene amplified in human sarcomas, encodes a new member of the transmembrane 4 superfamily of proteins  
  Jankowski SA, Mitchell DS, Smith SH, Trent JM, Meltzer PS, Oncogene, 1/1/1994
• Detection of chromosome 12q amplification in sarcomas by chromosome microdissection and interphase FISH  
  Mitchell DS, Guan, XY, Meltzer PS, Int J Oncol, 1/1/1994
• Final height after treatment for childhood acute lymphocytic leukemia: comparison of no cranial irradiation with 1800 and 2400 centigrays of cranial irradiation  
  Sklar C, Mertens A, Walter A, Mitchell D, Nesbit M, O'Leary M, Hutchinson R, Meadows A, Robison L, J Pediatr, 1/1/1993
• Isolation of a yeast artificial chromosome clone that spans the (12;16) translocation breakpoint characteristic of myxoid liposarcoma  
  Gemill RM, Paulien S, Dougherty C, Mendez M, Bolin R, Liao M, Mitchell D, Jankowski S, Trent JM, Berger C, Sandberg AA, Meltzer PS, Cancer Genetics and Cytogenetics, 1/1/1992
• Ia-Positive macrophages bind and internalize viable lymphocytes in murine thymus  
  Epstein HD, Mitchell DS, Hunt JS, Wood GW, Cellular Immunol, 1/1/1985
• Localization and characterization of macrophages in murine uterus  
  Hunt JS, Manning LS, Mitchell DS, Wood GW, J. Leukocyte Biol, 1/1/1985
• Localization and characterization of macrophages in murine uterus  
  Hunt JS, Manning LS, Mitchell DS, Wood GW, J Leukocyte Biol, 1/1/1985
• Join now to see all

Abstracts/Posters

• The Signature Study: Molecular Analysis of Pediatric Tumors with Establishment of Tumor Models in a Biology Study
  VanSickle, E, Zhao P, Mitchell D, Foley J, Steinbrecher J, Rich M, Nagulapally A, Bond J, Hendricks W, Dexheimer T, Neubig R, Saulnier Sholler G, American Association of Cancer Research (AACR), Washington, DC, 1/1/2017
• Mitchell D. Single Center Review of Second Malignancies in Childhood Cancer Survivors
  Timmer CM, Qu T, Scibienski BA, Braunreiter C, Pediatric Academic Societies, Baltimore, MD, 1/1/2016
• Primary Bone Lymphoma in Adolescents and Young Adults Treated with R-CHOP Chemotherapy
  Braunreiter CL, Kurt BA, Mitchell D, American Society of Pediatric Hematology/Oncology Annual Meeting, Phoenix, AZ, 1/1/2015
• Chemotherapy Resistant Histiocytic Sarcoma Responsive to Thalidomide and Lenalidomide
  Mitchell D, Fulton B, Steensma M, American Society of Pediatric Hematology/Oncology Annual Meeting, Chicago, IL, 1/1/2014
• A Feasibility Trial using Molecular-Guided Therapy for the Treatment of Patients with Refractory or Recurrent Neuroblastoma
  Saulnier Sholler G, Bergendahl G, Vander Werff A, Ferguson W, Roberts W, Eslin D, Kraveka J, Kaplan J, Mitchell D, Parikh N, Neville K, Ashikaga T, Bond J, Hanna G, Me..., American Society of Pediatric Hematology/Oncology (ASPHO) Annual Meeting, Chicago, IL, 1/1/2014
• Sustained Clinical Response to Treatment Directed by Genomic Expression Profiling Suggests mTOR Signaling is an Effective Target in Choroid Plexus Carcinoma
  Cornelius A, Foley J, Mitchell D, Nagulapally A, Bond J, Huntelman M, Corneveaux J, Trent J, Saulnier Sholler G, American Association of Cancer Research (AACR) M-Tor Meeting, Philadelphia, PA, 1/1/2014
• A Phase 1 Trial of DFMO as a Single Agent and in Combination with Etoposide in Patients with Refractory or Recurrent Neuroblastoma
  Saulnier Sholler G, Gerner E, Bergendahl G, LaFleur B, VanderWerff A, Ashilkaga T, Ferguson W, Roberts W, Wada R, Eslin D, KravekaJ, Kaplan J, Mitchell D, Parikh N, N..., American Association for Cancer Research Annual Meeting, Washington, DC, 1/1/2013
• A Feasibility Trial using Molecular-Guided Therapy for the Treatment of Patients with Refractory or Recurrent Neuroblastoma
  Saulnier Sholler G, Bergendahl G, Vander Werff A, Dutta A, Ferguson W, Roberts W, Eslin D, Kraveka J, Kaplan J, Mitchell D, Parikh N, Neville K, Ashikaga T, Bond J, Ha..., American Association for Cancer Research Annual Meeting, Washington, DC, 1/1/2013
• Primary Bone Lymphoma in a Young Adult Patient: A Chromothripsis Event?
  Braunreiter C, Kurt B, Mitchell D, Trent J, Hostetter G, Fourth International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin's Lymphoma, British Journal of Haematology, 1/1/2012
• A Pilot Trial Testing the Feasibility of using Molecular-Guided Therapy in Patients with Refractory or Recurrent Neuroblastoma
  Sholler GS, Kahn J, Ferguson W, Bergendahl G, Lenox SR, Bond J, Merchant M, Roberts W, Mitchell D, Eslin D, Kravecka J, Kaplan J, Parikh N, Malempati S, Hanna G, Kaman..., American Association of Cancer Research, Orlando, FL, 1/1/2011
• Venous Thromboembolism in Children and Adolescents taking Hormonal Therapy
  Mitchell D, Cain N, Grand Rapids Medical Education Partner Research Day, Grand Rapids, MI, 1/1/2011
• The "Malignant" Manifestations of Histoplasmosis in the Pediatric Population
  Khilanani A, Helton H, Dahl KM, Mitchell D, Grand Rapids Medical Education and Research Center Community Health Research Day, Grand Rapids, MI, 1/21/2010
• Final height after treatment for childhood acute lymphocytic leukemia.
  Sklar C, Mertens A, Walter A, Mitchell D, Nesbit M, O'Leary M, Hutchinson R, Meadows A, Robison L, American Society of Clinical Oncology, San Diego, CA, 1/1/1992
• FDG PET studies of pediatric tumors.
  Shulkin BL, Mitchell DS, Prakash D, Dole MG, Ungar DR, Koeppe RA, Kuhl DE, Hutchinson RJ, 5th Biennial Congress of the South African Society of Nuclear Medicine, 1/1/1992
• FDG PET studies of pediatric tumors
  Shulkin BL, Mitchell DS, Prakash D, Dole MG, Ungar DR, Koeppe RA, Kuhl DE, Hutchinson RJ, 5th Biennial Congress of the South African Society of Nuclear Medicine, 1/1/1992
• Join now to see all

Lectures

• Osteosarcoma and Ewing Sarcoma: an Overview 
  1/1/2016
• A Phase II Prevention Trial of DFMO in Patients with High-Risk Neuroblastoma in Remission Prevents Relapse and Increases Event-Free and Overall Survival 
  Minneapolis, MN - 1/1/2016
• Childhood and Adolescent Lymphomas 
  Grand Rapids, MI - 1/1/2015
• Second Malignancies in Childhood Cancer Survivors 
  1/1/2015
• A Community Assessment of the Management of Hereditary Hemochromatosis and the role of the Primary Care Provider 
  Helen DeVos Children's Hospital - 1/1/2014
• Risk Factors for the Development of Hepatoblastoma 
  1/1/2013
• Adolescents, Estrogen and Thrombosis 
  Helen DeVos Children's Hospital - 1/1/2011
• Molecular Guided Therapy - Collaboration Between Helen DeVos Children's Hospital and Van Andel Institute 
  Van Andel Institute - 1/1/2011
• Medical Professionalism 
  1/1/2011
• Inherited Bleeding Disorders/Management of Blood Avoidant Patients 
  1/1/2007
• Bone Tumors In Children and Adolescents 
  DeVos Children’s Hospital, Grand Rapids, MI - 1/1/2007
• Clotting Problems In Children 
  DeVos Children’s Hospital, Grand Rapids, MI - 1/1/2004
• Von Willebrand's Disease 
  DeVos Children's Hospital, Grand Rapids MI - 1/1/2002
• Von Willebrand’s Disease 
  DeVos Children’s Hospital, Grand Rapids, MI - 1/1/2002
• Fibrodysplasia Ossificans Progressiva 
  DeVos Children’s Hospital, Grand Rapids, MI - 1/1/2000
• Hepatitis Treatment Options 
  Dearborn, MI - 1/1/1998
• Hemophilia: An Optimistic Future 
  Detroit, MI - 1/1/1998
• Abdominal Masses in Children 
  Grand Rapids, MI - 1/1/1995
• Hereditary Cancer Syndromes 
  DeVos Children’s Hospital, Grand Rapids, MI - 1/1/1995
• Amplification of 12q 13-14 in Soft Tissue Sarcomas 
  St. Jude Children’s Research Hospital, Memphis, TN - 1/1/1993
• Pediatric Abdominal Neoplasms 
  Holland Hospital, Holland, MI - 1/1/1993
• p53 and Li-Fraumeni Syndrome 
  University of Michigan, Ann Arbor, MI - 1/1/1992
• 53 and Li-Fraumeni Syndrome 
  University of Michigan, Ann Arbor MI - 1/1/1992
• Join now to see all